Nuvalent, Inc. (NUVL)

100.50 -3.56 (-3.42%) USD  |  NASDAQ  |  Feb 20, 16:00
98.57 -1.93 (-1.92%) Pre-Market: 08:41
More

Nuvalent Other Receivables (Quarterly)

Other Receivables (Quarterly) Chart

View Other Receivables (Quarterly) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Receivables (Quarterly) Range, Past 5 Years

View Other Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Receivables (Quarterly) Benchmarks

View Other Receivables (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Kodiak Sciences, Inc. --